Cuba Begins China Registration of Diabetic Ulcer Drug
2009-05-08
ChinaBio Today -- Cuban officials have begun the registration process in China for Heberprot-B, an innovative treatment for chronic diabetic ulcers in the extremities. Developed by Havana’s Center for Genetic Engineering and Biotechnology (CIGB), Heberprot-B is said to reduce the need for amputation by 50%. The drug underwent Cuban clinical trials in more than 300 patients, and has been approved for use there since 2006. More details...
机构
-适应症
靶点
-来和芽仔聊天吧
立即开始免费试用!
智慧芽新药情报库是智慧芽专为生命科学人士构建的基于AI的创新药情报平台，助您全方位提升您的研发与决策效率。
立即开始数据试用!
智慧芽新药库数据也通过智慧芽数据服务平台，以API或者数据包形式对外开放，助您更加充分利用智慧芽新药情报信息。